Siponimod vs placebo
Withdrawals due to adverse events · people with multiple sclerosis
Siponimod showed no clear difference in number of participants who withdrew due to AEs at 6 months compared with placebo (low certainty).
1 finding from 1 review
- RR 1.52 [0.85, 2.71]2 studies · 1739 participantsLow